Theratechnologies Inc. (NASDAQ:THTX) Q1 2024 Earnings Conference Call April 10, 2024 8:30 AM ET

Company Participants

Julie Schneiderman - Senior Director, Communications & Corporate Affairs
Paul Levesque - President & CEO
Philippe Dubuc - SVP & CFO
Christian Marsolais - SVP & Chief Medical Officer
John Leasure - Global Commercial Officer

Conference Call Participants

Carvey Leung - Cantor Fitzgerald
William Maughan - Canaccord Genuity

Operator

Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Theratechnologies First Quarter 2024 Earnings Call. We would like to remind everyone that all figures on this call are quoted in U.S. dollars. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session with analysts, instructions will be provided at that time for you to queue up for questions.

Following the analyst Q&A session, investors wishing to submit a question, may do so by clicking the Ask a Question link on the webcast platform. [Operator Instructions] I would like to remind everyone that this conference call is being recorded today, Wednesday, April 10, 2024 at 8:30 A.M. Eastern Time.

I will now turn the call over to Julie Schneiderman, Senior Director, Communications, and Corporate Affairs at Theratechnologies. Julie, please go ahead.

Julie Schneiderman

Thank you, operator, and good morning, everyone. On the call today will be Theratechnologies’ President and Chief Executive Officer, Mr. Paul Levesque; and Senior Vice President and Chief Financial Officer, Mr. Philippe Dubuc. During the Q&A session, we will be joined by Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer; and Mr. John Leasure, the company's Global Commercial Officer.

Before we begin, I'd like to remind everyone that remarks today contain forward-looking statements regarding the company's current and future plans, expectations and intentions with respect to future events. Forward-looking statements are based on assumptions, and there are risks that -- there are risks that results obtained by Theratechnologies may differ materially from those statements.

As such, the company cannot guarantee that any forward-looking statement will materialize and you are cautioned not to place undue reliance on them. The company refers current and potential investors to the forward-looking information section of Theratechnologies management's discussion and analysis issued this morning and available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Forward-looking statements represent Theratechnologies' expectations as of this morning, April 10, 2024.

Additionally, today, the company is using the term adjusted EBITDA, which is not a financial measure under International Financial Reporting Standards, IFRS or U.S. generally accepted accounting principles, U.S. GAAP. Adjusted EBITDA excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions rather than the results of day-to-day operations. Theratechnologies believes that this measure can be a useful indicator of its operational performance and financial condition from one period to another.